R & D systems INC:1107462 [14-005278] custom tocriscreen - 686 compounds, 5 MG each, $36 each-quotation number QT32520-ajit jadhav
Ended Awarded
- Contract number
- HHSN31900002
- Awardee
-
Research And Diagnostic Systems, Inc. UEI WAYSQU5HJYT9 Part of Bio-Techne Corporation
- Awarding agency
-
National Center for Advancing Translational Sciences
National Institutes of Health, Department of Health and Human Services
- Obligated
- $24,741
Award facts
- Contract value 100% obligated
- $24,740.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6810 Chemicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Minneapolis, MN 55413, USA
Award details come from SAM.gov/FPDS.
About this award
Research and Diagnostic Systems, Inc. (R&D Systems), a Minneapolis-based subsidiary of Bio-Techne Corporation, was awarded a Blanket Purchase Agreement (BPA) call valued at $24,740.50 by the National Center for Advancing Translational Sciences (NCATS) on September 18, 2014. The contract, executed under quotation number QT32520, was for the delivery of a custom TOCRIScreen compound library consisting of 686 compounds at 5 milligrams each, priced at $36 per unit. This was a firm fixed-price, non-set-aside procurement with an ultimate completion date of August 31, 2015, performed at R&D Systems' facility in Minneapolis, Minnesota.
The award represents a typical task order fulfillment under R&D Systems' broader $10 million BPA with the Office of Logistics and Acquisition Operations, which runs through September 30, 2025. This BPA enables flexible ordering of biological materials and laboratory supplies supporting biomedical research across multiple NIH institutes and centers. The specialized compound library supplied under this contract supports NCATS' mission to advance translational science—the application of basic research findings to develop practical medical treatments and diagnostics. R&D Systems' established reputation as a critical supplier of research reagents, proteins, and specialized materials to federal agencies positioned the company to fulfill this specialized procurement requirement.
Quick answers
Who was awarded contract HHSN31900002?
HHSN31900002 was awarded to Research And Diagnostic Systems, Inc. by National Center for Advancing Translational Sciences (National Institutes of Health) on September 18, 2014.
How much is contract HHSN31900002 worth?
The government has obligated $24,741 on HHSN31900002.
Is contract HHSN31900002 an order under another contract?
Yes. HHSN31900002 is a BPA call under HHSN263199900050140B, a blanket purchase agreement.
Was contract HHSN31900002 competed?
The extent of competition for HHSN31900002 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award